Michael Rukstalis

Michael Rukstalis has a diverse and extensive work experience in the field of biomedical research. Michael is currently serving as the Senior Lab Director at TreeFrog Therapeutics since June 2023. Prior to this, they worked at Sana Biotechnology, Inc. where they held the position of Senior Director from July 2019 to March 2023.

From May 2017 to July 2019, Michael worked as a Senior Research Scientist I at the Broad Institute of MIT and Harvard. Before that, they served as a Principal Investigator at Pfizer Pharmaceuticals from May 2009 to May 2017.

Michael's earlier experience includes working as an Instructor in Medicine at Massachusetts General Hospital from September 2006 to November 2010 and as a Postdoctoral Fellow from July 2003 to August 2006. Additionally, they worked as a Research Associate at the Howard Hughes Medical Institute from September 2004 to August 2006.

Overall, Michael Rukstalis has consistently held senior positions in various reputable organizations, showcasing their expertise and dedication in the field of biomedical research.

Michael Rukstalis pursued their education beginning in 1992 at the University of Massachusetts Amherst, where they earned a Bachelor of Science degree in Biological Sciences in 1997. Michael then proceeded to further their studies at Purdue University from 1997 to 2003, earning a PhD in Genetics/Biological Sciences.